Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Dec 28;12(6):463-9.
doi: 10.1007/BF00561067.

Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension

Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension

L M Wing et al. Eur J Clin Pharmacol. .

Abstract

The effect of oral doses of 300 microgram of clonidine hydrochloride on blood pressure, sedation and saliva production in 5 essential hypertensives were qualitatively similar to the effects in normotensive subjects. Peak plasma clonidine concentration (1.34 +/- 0.28 ng/ml) and plasma half-life (10.0 +/- 0.8 h) were similar to normotensives. During chronic oral dosing there was no evidence of drug accumulation. Some tolerance to the sedative and salivary flow effects occurred but no tolerance to the hypotensive effect was observed. There was a linear relationship between reduction in saliva flow and plasma levels of clonidine. The hypotensive effect was also related to plasma level at low concentrations. At plasma levels greater than 1.5 ng/ml the hypotensive effect was diminished. This loss of effect at high plasma concentration may be related to the peripheral, post-synaptic alpha-adrenoceptor agonist action of the drug.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1973 Sep-Oct;14(5):847-51 - PubMed
    1. Arzneimittelforschung. 1967 Mar;17(3):292-300 - PubMed
    1. Eur J Pharmacol. 1969 Apr;6(1):8-12 - PubMed
    1. Clin Pharmacol Ther. 1976 Jan;19(1):11-7 - PubMed
    1. Circ Res. 1971 May;28(5):Suppl 2:53-69 - PubMed

LinkOut - more resources